Company filings profile · CIK 0001367083
Sonoma Pharmaceuticals, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Sonoma Pharmaceuticals, Inc. (SNOA): 14 filings in the last 90 days vs 14 in the prior 90 (filing-velocity steady · 1×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Oct 7, 2026. Source-linked, daily-refreshed.
Material 8-K events — Sonoma Pharmaceuticals, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Oct 6, 2026 | Entry into a Material Agreement; Item 3.03; Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Sep 17, 2026 | Item 5.07 | ↗ |
| Aug 19, 2026 | Item 5.07 | ↗ |
| Jun 18, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Apr 30, 2026 | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Apr 9, 2026 | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Jan 28, 2026 | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Jan 12, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
Watch Sonoma Pharmaceuticals, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Oct 6, 2026 | 8-A12B/A | AMENDMENT TO FORM 8-A12B | ↗ |
| Oct 6, 2026 | 8-K | Entry into a Material Agreement; Item 3.03; Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Sep 17, 2026 | 8-K | Item 5.07 | ↗ |
| Aug 19, 2026 | 8-K | Item 5.07 | ↗ |
| Aug 6, 2026 | 10-Q | FORM 10-Q FOR JUN 2026 | ↗ |
| Jul 28, 2026 | DEF 14A | DEFINITIVE PROXY STATEMENT | ↗ |
| Jul 23, 2026 | DEFA14A | NOTICE OF ADJOURNMENT | ↗ |
| Jul 9, 2026 | 4 | ↗ | |
| Jul 9, 2026 | 4 | ↗ | |
| Jul 9, 2026 | 4 | ↗ | |
| Jul 9, 2026 | 4 | ↗ | |
| Jul 9, 2026 | 4 | ↗ | |
| Jul 9, 2026 | 4 | ↗ | |
| Jul 9, 2026 | S-8 | FORM S-8 | ↗ |
| Jun 24, 2026 | DEFA14A | FORM DEFA14A | ↗ |
| Jun 18, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Jun 18, 2026 | 424B5 | PROSPECTUS SUPPLEMENT | ↗ |
| Jun 16, 2026 | 10-K | FORM 10-K FOR MAR 2026 | ↗ |
| May 5, 2026 | DEF 14A | DEFINITIVE PROXY STATEMENT | ↗ |
| Apr 30, 2026 | 8-K | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Apr 27, 2026 | 424B4 | PROSPECTUS | ↗ |
| Apr 27, 2026 | PRE 14A | FORM PRE 14A | ↗ |
| Apr 23, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Apr 23, 2026 | S-1/A | AMENDMENT NO. 1 TO FORM S-1 | ↗ |
| Apr 22, 2026 | CORRESP | ↗ | |
| Apr 22, 2026 | CORRESP | ↗ | |
| Apr 17, 2026 | S-1 | FORM S-1 | ↗ |
| Apr 10, 2026 | UPLOAD | ↗ | |
| Apr 9, 2026 | DRS | ↗ | |
| Apr 9, 2026 | 8-K | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Feb 10, 2026 | 10-Q | FORM 10-Q FOR DEC 2025 | ↗ |
| Feb 9, 2026 | 3 | ↗ | |
| Jan 28, 2026 | 8-K | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Jan 12, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Jan 2, 2026 | 4 | ↗ | |
| Jan 2, 2026 | 4 | ↗ | |
| Jan 2, 2026 | 4 | ↗ | |
| Jan 2, 2026 | 4 | ↗ | |
| Jan 2, 2026 | 4 | ↗ | |
| Jan 2, 2026 | 4 | ↗ |